Dutch pharmacy fed slams health funds
The Netherlands pharmacy federation, the KNMP, has attacked the newly-privatized health fund regime, claiming the system is leading insurers to meddle in drug prescribing. It said the health insurance companies were "installing" themselves in the pharmacies and medical practices and intervening in matters of prescription detail affecting drug products to which patients had a right.
To keep costs down in a competitive market, some of the health funds are only reimbursing one type of drug product - namely the cheapest available. The KNMP says this works to the disadvantage of patients used to a particular drug for long-term treatment. The Dutch system has now been privatized for 12 months as part of what is claimed to be an unsuccessful reform.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze